Literature DB >> 26819052

Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.

Nicolas Guillaume1, Pascale Loiseau2, Katia Gagne3, Hélène Moins Teissserenc4, Jean-Michel Cayuela5, Guylaine Henry6, Marie Robin7, Régis Peffault de Latour7, Eliane Gluckman8, Gérard Socié9, Christelle Retiere10, Nicolas Dulphy11, Antoine Toubert12.   

Abstract

Keywords:  cord blood transplantation; immunogenetics; natural killer cells

Mesh：

Substances：

Year:  2016        PMID： 26819052      PMCID： PMC5004361          DOI： 10.3324/haematol.2015.138883

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation.

Authors:  Philippe Haas; Pascale Loiseau; Ryad Tamouza; Jean-Michel Cayuela; Hélène Moins-Teisserenc; Marc Busson; Guylaine Henry; Christine S Falk; Dominique Charron; Gérard Socié; Antoine Toubert; Nicolas Dulphy
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

2.  NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Authors:  Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-01-22       Impact factor: 22.113

3.  NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Julie Curtsinger; Xianghua Luo; Edmund K Waller; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

4.  Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

Authors:  Duncan Purtill; Katherine Smith; Sean Devlin; Richard Meagher; Joann Tonon; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Cladd E Stevens; Juliet N Barker
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

Review 5.  Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant.

Authors:  Andrea Velardi; Loredana Ruggeri; Antonella Mancusi
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

6.  Human NK cell education by inhibitory receptors for MHC class I.

Authors:  Nicolas Anfossi; Pascale André; Sophie Guia; Christine S Falk; Sophie Roetynck; C Andrew Stewart; Violette Breso; Coralie Frassati; Denis Reviron; Derek Middleton; François Romagné; Sophie Ugolini; Eric Vivier
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

7.  MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment.

Authors:  Julie M Elliott; Joseph A Wahle; Wayne M Yokoyama
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

8.  Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.

Authors:  Judith A E Somers; Anneke Brand; Yvette van Hensbergen; Arend Mulder; Machteld Oudshoorn; Kees Sintnicolaas; Jan-Willem Gratama; J H Frederik Falkenburg; Eric Braakman; Jan J Cornelissen
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-03       Impact factor: 5.742

9.  Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Authors:  Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Sarah Cooley; Harriet Noreen; Juliet N Barker; Todd DeFor; Michael R Verneris; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

Review 10.  Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.

Authors:  Vanderson Rocha; Eliane Gluckman
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.